The role of IGF-1 and IGF-BP3 in predicting skeletal metastases in breast cancer patients

dc.contributor.authorKaya, H.
dc.contributor.authorKarahan, C. Can
dc.contributor.authorAr, S.
dc.contributor.authorAguloglu, N.
dc.date.accessioned2024-04-24T17:44:21Z
dc.date.available2024-04-24T17:44:21Z
dc.date.issued2008
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpageS286en_US
dc.identifier.issn1619-7070
dc.identifier.startpageS286en_US
dc.identifier.urihttps://hdl.handle.net/11468/21956
dc.identifier.volume35en_US
dc.identifier.wosWOS:000208690701366
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofEuropean Journal of Nuclear Medicine and Molecular Imaging
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleThe role of IGF-1 and IGF-BP3 in predicting skeletal metastases in breast cancer patientsen_US
dc.titleThe role of IGF-1 and IGF-BP3 in predicting skeletal metastases in breast cancer patients
dc.typeConference Objecten_US

Dosyalar